Cynthia Louise Flowers

Insider Reports History

Entity
Individual
Location
C/O G1 Therapeutics, 700 Park Offices Dr, Suite 200, P.O. Box 110341, Research Triangle Park, NC
Signature
/S/ Monica Roberts Thomas, attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Cynthia Louise Flowers:

Stock Role Class Num Shares Value Price $ Report Date Ownership
LISATA THERAPEUTICS, INC. Director Common Stock 49.2K $147K $2.99 Jan 9, 2024 Direct
G1 Therapeutics, Inc. Director Common Stock 0 $0 $2.51 Sep 18, 2024 Direct
G1 Therapeutics, Inc. Director Stock Option (right to buy) 0 Sep 18, 2024 Direct
Kadmon Holdings, Inc. Director Common Stock 0 $9.50 Nov 9, 2021 Direct
Kadmon Holdings, Inc. Director Stock Option (right to buy) 0 $5.54 Nov 9, 2021 Direct

Insider Reports Filed by Cynthia Louise Flowers

Symbol Company Period Transactions Value $ Form Type Date Filed Role
GTHX G1 Therapeutics, Inc. Sep 18, 2024 5 $0 4 Sep 18, 2024 Director
GTHX G1 Therapeutics, Inc. Jun 13, 2024 2 $0 4 Jun 14, 2024 Director
LSTA LISATA THERAPEUTICS, INC. Jan 9, 2024 1 $0 4 Jan 11, 2024 Director
GTHX G1 Therapeutics, Inc. Jun 15, 2023 2 $0 4 Jun 16, 2023 Director
LSTA LISATA THERAPEUTICS, INC. Jan 9, 2023 1 $0 4 Jan 11, 2023 Director
GTHX G1 Therapeutics, Inc. Jun 23, 2022 2 $0 4 Jun 24, 2022 Director
LSTA CALADRIUS BIOSCIENCES, INC. Jan 10, 2022 1 $0 4 Jan 12, 2022 Director
KDMN Kadmon Holdings, Inc. Nov 8, 2021 6 -$2.3M 4 Nov 9, 2021 Director
GTHX G1 Therapeutics, Inc. Jun 17, 2021 2 $0 4 Jun 21, 2021 Director
KDMN Kadmon Holdings, Inc. May 12, 2021 1 $0 4 May 13, 2021 Director